Research interests
Lead author of research on aspirin’s molecular effects and gene regulatory activity[16]
DV
Deepak Voora
As of 2029 · Last known relationship
As of 2029 · Last known relationship
Deepak Voora is a Duke cardiologist and professor whose work connects cardiovascular medicine with pharmacogenomics and precision medicine. He earned his M.D. from Northwestern University in 2002, completed Internal Medicine residency at Barnes-Jewish Hospital from 2002 to 2005, and trained in Cardiovascular Disease at Duke University Medical Center from 2006 to 2010. At Duke, he has been a member of the Center for Applied Genomics & Precision Medicine since 2010 and an executive team member since 2014. He was named founding director of PHASER in 2019, a Veterans pharmacogenetic-testing program. His research includes aspirin-related gene regulation and response signatures, statin pharmacogenetics, and genomic approaches to cardiovascular risk and medication selection.
Each topic is linked to its supporting source in Sources.
Training includes Research Principal Investigator for The VA Genomic Learning Health System: Implementing genomic medicine across diverse Veteran communities, Research Principal Investigator for Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease, Speaker in Session 2: Exploring ethical, equity, and regulatory implications for pharmacogenomics in psychiatric care, and Cardiovascular Disease fellowship at Duke University Medical Center, plus 13 more records.
Explore education and trainingAs of 2029
As of 2028
As of 2024
As of 2010
As of 2005
As of 2002
As of 2024
As of 2019
As of 2014
As of 2010
Lead author of research on aspirin’s molecular effects and gene regulatory activity[16]
Lead author of research using an aspirin response signature to identify risk of heart attack and death[17]
Research Investigator for Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations[13]
2018 to 2025